Skip to main content
Clinical Trials/DRKS00031139
DRKS00031139
Recruiting
Not Applicable

Identification and analysis of biomarkers for the course of demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosis - GRAMS

MPI-NAT0 sites1,000 target enrollmentJanuary 26, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosis
Sponsor
MPI-NAT
Enrollment
1000
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 26, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
MPI-NAT

Eligibility Criteria

Inclusion Criteria

  • Diagnosis Multiple Sclerosis or other demyelinating diseases of the CNS

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials